POMDOCTOR Financial Statements From 2010 to 2026

POM Stock   0.32  0.01  3.23%   
POMDOCTOR LIMITED's financial statements offer valuable quarterly and annual insights to potential investors, highlighting the company's current and historical financial position, overall management performance, and changes in financial standing over time. Key fundamentals influencing POMDOCTOR LIMITED's valuation are provided below:
There are over one hundred nineteen available trending fundamental ratios for POMDOCTOR LIMITED, which can be analyzed over time and compared to other ratios. Self-guided Investors are advised to check out POMDOCTOR LIMITED's recent fundamentals against the trend between 2010 and 2026 to make sure the company can sustain itself next year. As of the 12th of January 2026, Market Cap is likely to drop to about 2.6 B. In addition to that, Enterprise Value is likely to drop to about 2.9 B

POMDOCTOR LIMITED Total Revenue

374.24 Million

Check POMDOCTOR LIMITED financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among POMDOCTOR LIMITED's main balance sheet or income statement drivers, such as Depreciation And Amortization of 147 K, Interest Expense of 14.2 M or Total Revenue of 374.2 M, as well as many indicators such as Price To Sales Ratio of 13.42, Dividend Yield of 0.0 or Days Sales Outstanding of 19.31. POMDOCTOR financial statements analysis is a perfect complement when working with POMDOCTOR LIMITED Valuation or Volatility modules.
  
Build AI portfolio with POMDOCTOR Stock
Check out the analysis of POMDOCTOR LIMITED Correlation against competitors.

POMDOCTOR LIMITED Balance Sheet

Current ValueLast YearHistorical Average 10 Year Trend
Total Assets50.5 M53.2 M26.4 B
Pretty Stable
Short and Long Term Debt Total481.9 M507.3 M7.6 B
Pretty Stable
Total Current Liabilities195.7 M206 MB
Slightly volatile
Net Debt473.5 M498.5 M7.4 B
Pretty Stable
Accounts Payable21.7 M22.8 M792.7 M
Pretty Stable
Cash8.4 M8.8 M199.4 M
Pretty Stable
Non Current Assets Total9.5 M10 M23.7 B
Pretty Stable
Cash And Short Term Investments6.5 M6.9 M361 M
Pretty Stable
Net Receivables12.8 M13.5 M1.1 B
Slightly volatile
Good Will8.1 B7.7 BB
Slightly volatile
Common Stock Shares Outstanding129.4 M136.2 M465.9 M
Slightly volatile
Liabilities And Stockholders Equity50.5 M53.2 M26.9 B
Pretty Stable
Non Current Liabilities Total2.1 B2.3 B11.9 B
Pretty Stable
Other Current Assets6.2 M6.6 M1.2 B
Pretty Stable
Total Liabilities2.3 B2.5 B20.1 B
Pretty Stable
Total Current Assets41 M43.1 M2.7 B
Pretty Stable
Short Term Debt63.6 M66.9 M447 M
Pretty Stable
Common Stock4.8 K5.1 K3.4 B
Very volatile
Current Deferred Revenue1.5 M1.6 M2.4 B
Slightly volatile
Inventory7.8 M8.2 M92.8 M
Slightly volatile
Intangible Assets29.6 M33.3 M36.4 M
Slightly volatile
Long Term Debt371.8 M419.9 M328.3 M
Slightly volatile
Capital Lease Obligations4.8 M2.8 M5.3 M
Pretty Stable
Short and Long Term Debt49.8 M83.9 M33.6 M
Slightly volatile
Capital StockK5.1 K3.2 K
Slightly volatile
Property Plant And Equipment Gross12.2 M13 M11 M
Slightly volatile

POMDOCTOR LIMITED Income Statement

Current ValueLast YearHistorical Average 10 Year Trend
Interest Expense14.2 M14.9 M448.1 M
Pretty Stable
Total Revenue374.2 M393.9 M9.7 B
Pretty Stable
Gross Profit40.8 M42.9 MB
Slightly volatile
Other Operating Expenses402.4 M423.6 M9.5 B
Pretty Stable
Cost Of Revenue322.1 M339.1 M3.6 B
Very volatile
Total Operating Expenses62.8 M66.1 M3.2 B
Very volatile
Selling General Administrative9.9 M10.7 M11.7 M
Very volatile
Selling And Marketing Expenses82 M50.7 M203 M
Slightly volatile
Research Development3.6 M3.5 M2.5 M
Slightly volatile

POMDOCTOR LIMITED Cash Flow Statement

Current ValueLast YearHistorical Average 10 Year Trend
Begin Period Cash Flow7.4 M7.8 M511.3 M
Pretty Stable
End Period Cash Flow8.4 M8.8 M211.1 M
Very volatile
Net Borrowings26.8 M19.6 M12 M
Slightly volatile

Financial Ratios

Current ValueLast YearHistorical Average 10 Year Trend
Price To Sales Ratio13.4211.713.4564
Slightly volatile
Days Sales Outstanding19.3114.368.4711
Slightly volatile
Average Payables26.8 M30.2 M32.9 M
Slightly volatile
Capex To Depreciation0.310.320.8756
Slightly volatile
EV To Sales14.9713.1514.9831
Slightly volatile
ROIC0.610.510.9968
Slightly volatile
Inventory Turnover19.2928.9521.4921
Slightly volatile
Days Of Inventory On Hand17.2413.0517.2391
Slightly volatile
Payables Turnover5.5510.476.0418
Slightly volatile
Sales General And Administrative To Revenue0.0530.03990.0734
Slightly volatile
Average Inventory7.4 M9.4 M8.5 M
Slightly volatile
Research And Ddevelopement To Revenue0.0150.01010.0175
Slightly volatile
Capex To Revenue1.0E-41.0E-43.0E-4
Slightly volatile
Cash Per Share0.03220.05810.0266
Slightly volatile
Days Payables Outstanding65.9536.0864.1971
Slightly volatile
Income Quality0.590.390.3363
Slightly volatile
ROE0.08170.07280.0925
Slightly volatile
Current Ratio0.210.190.1947
Slightly volatile
Receivables Turnover24.9926.31211
Slightly volatile
Capex Per Share7.0E-44.0E-49.0E-4
Slightly volatile
Average Receivables23.9 M26.8 M29.3 M
Slightly volatile
Revenue Per Share1.872.61.9899
Slightly volatile
Interest Debt Per Share2.733.453.1194
Slightly volatile
Debt To Assets11.2410.9715.1454
Slightly volatile
Operating Cycle31.8424.5725.2661
Slightly volatile
Days Of Payables Outstanding65.9536.0864.1971
Slightly volatile
Ebt Per Ebit2.711.671.6173
Slightly volatile
Return On Capital Employed0.360.220.6844
Slightly volatile
Quick Ratio0.160.140.1257
Slightly volatile
Net Income Per E B T3.213.452.6039
Slightly volatile
Cash Ratio0.02380.03840.0235
Slightly volatile
Days Of Inventory Outstanding17.2413.0517.2391
Slightly volatile
Days Of Sales Outstanding19.3114.368.4711
Slightly volatile
Free Cash Flow Operating Cash Flow Ratio1.11.151.0169
Slightly volatile
Fixed Asset Turnover502668534
Slightly volatile
Debt Ratio11.2410.9715.1454
Slightly volatile
Price Sales Ratio13.4211.713.4564
Slightly volatile
Asset Turnover7.768.529.8336
Slightly volatile
Gross Profit Margin0.20.160.2221
Slightly volatile
Return On Equity0.08170.07280.0925
Slightly volatile

POMDOCTOR LIMITED Valuation Data

Current ValueLast YearHistorical Average 10 Year Trend
Market Cap2.6 B3.1 B3.1 B
Pretty Stable
Enterprise Value2.9 B3.5 B3.4 B
Pretty Stable

POMDOCTOR Fundamental Market Drivers

About POMDOCTOR LIMITED Financial Statements

POMDOCTOR LIMITED investors utilize fundamental indicators, such as revenue or net income, to predict how POMDOCTOR Stock might perform in the future. Analyzing these trends over time helps investors make informed market timing decisions. For further insights, please visit our fundamental analysis page.
Last ReportedProjected for Next Year
Current Deferred Revenue1.6 M1.5 M
Total Revenue393.9 M374.2 M
Cost Of Revenue339.1 M322.1 M
Sales General And Administrative To Revenue 0.04  0.05 
Research And Ddevelopement To Revenue 0.01  0.02 
Revenue Per Share 2.60  1.87 
Ebit Per Revenue(0.07)(0.07)

Building efficient market-beating portfolios requires time, education, and a lot of computing power!

The Portfolio Prophet is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.

Try AI Portfolio Prophet
When determining whether POMDOCTOR LIMITED is a strong investment it is important to analyze POMDOCTOR LIMITED's competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact POMDOCTOR LIMITED's future performance. For an informed investment choice regarding POMDOCTOR Stock, refer to the following important reports:
Check out the analysis of POMDOCTOR LIMITED Correlation against competitors.
You can also try the Cryptocurrency Center module to build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency.
Is Pharmaceutical Retailers space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of POMDOCTOR LIMITED. If investors know POMDOCTOR will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about POMDOCTOR LIMITED listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
The market value of POMDOCTOR LIMITED is measured differently than its book value, which is the value of POMDOCTOR that is recorded on the company's balance sheet. Investors also form their own opinion of POMDOCTOR LIMITED's value that differs from its market value or its book value, called intrinsic value, which is POMDOCTOR LIMITED's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because POMDOCTOR LIMITED's market value can be influenced by many factors that don't directly affect POMDOCTOR LIMITED's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between POMDOCTOR LIMITED's value and its price as these two are different measures arrived at by different means. Investors typically determine if POMDOCTOR LIMITED is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, POMDOCTOR LIMITED's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.